For investors aiming to achieve substantial price gains, a mixed method of fundamental and technical study can be an effective plan. The aim is to find companies with good basic business expansion—firm and quickening sales and profits—while also determining a good time for purchase based on market movement. This process selects for shares showing very good fundamental expansion measures, firm money condition, and acceptable earnings, then adds a technical view to locate those showing helpful price formations, like periods of little movement near peaks, indicating a possible price rise is near. This combination of firm business speed and good technical form seeks to locate chances where fundamental potential matches with market entry timing.
Penumbra Inc (NYSE:PEN), a top company in creating and making new medical tools for vascular clot removal, recently appeared from a filter created on this exact approach. The firm seems to offer an interesting example where quickening fundamental results meets a technical price picture that could be preparing for its next upward move.
Fundamental Expansion Driver
At its center, the investment idea for Penumbra depends on its firm and provable expansion path. The company’s fundamental report from ChartMill gives it a firm Expansion Rating of 8 out of 10, a main part of the filtering tactic. This number is supported by notable measurable outcomes:
- Profit Growth: Penumbra’s Earnings Per Share (EPS) increased by a notable 36.47% over the last year, with a steady yearly growth rate of 24.23% over recent years. Experts predict this firm speed to persist, estimating average yearly EPS growth of 25.21% in the next years.
- Sales Speed: The top line is also firm, with sales rising 14.61% last year and keeping a nearly 17% yearly growth rate over a longer time. Future sales are predicted to grow at a firm 13.37% each year.
- Money Strength: Supporting this expansion is a very good money condition profile, shown by a ChartMill Condition Rating of 8. The company has a very firm money sheet with very little owed money (Debt/Equity of 0.02) and high cash availability (Current Ratio of 6.73), giving good supplies to put money into new ideas and market growth without money pressure.
While its Earnings Rating is a medium 6, main measures like Return on Equity (12.07%) and Operating Margin (12.95%) place well within the competing Health Care Equipment & Supplies field. This shows the company is not only increasing sales, but is doing so effectively and changing that expansion into profits.
Technical Pattern and Market Place
A firm fundamental account is most effective when the market’s price movement starts to show and expect that account. According to Penumbra’s technical analysis report, the share currently has a high technical rating of 8, with a specific Pattern Rating of 7, showing a good formation for possible entry.
- Direction Agreement: Both the long-period and short-period directions for PEN are rated as good, matching the share’s course with the current good short-period direction of the wider S&P 500.
- Little Movement Near Highs: The report states the share has been changing hands in a band over the last month and is now placed near the bottom of that band, after a step back from recent peaks. This kind of activity can show a time of little movement, where the share absorbs earlier increases and gathers force for a possible upward move.
- Clear Floor and Ceiling: The technical study finds a clear floor zone just under the current price and a notable ceiling level above. The "lower price swings while prices have been in little movement" is a usual trait of a tightening formation that often comes before a directional price rise. The pattern indicates that a move above a close activation point could show a restart of the upward direction.
Price Context
Expansion shares often sell at high prices, and Penumbra is not different. Its Price-to-Earnings (P/E) ratio is high compared to the wider market average. However, the fundamental analysis gives important background: this high price is partly explained by the company's better expansion rates and high earnings within its industry. The main point for expansion investors is if the company can keep performing and expanding to match its price. The firm predicted expansion rates and leading market place in new clot removal technology are the reasons supporters say will explain the current price over time.
Summary
Penumbra Inc shows the kind of chance a mixed expansion-and-technical tactic tries to discover. The company has a confirmed, high-speed expansion driver led by new medical technology, supported by a very firm money sheet. At the same time, its share price picture shows a helpful technical position, with good directions and a recent period of little movement that could be making a foundation for its next rise. For investors concentrated on expansion, the matching of these fundamental and technical points makes PEN a share deserving of more detailed study.
Interested in locating more shares that match this outline of firm expansion joined with a good technical pattern? You can use the same filter with our stock screener tool here.
Disclaimer: This article is for information and learning only and does not make investment guidance, a suggestion, or a deal or request to buy or sell any securities. The information shown is based on given numbers and should not be the only base for making any investment choice. Investors should do their own separate study and talk with a registered money advisor before making any investment choices. Past results are not a guide for future results. Investing includes risk, including the possible loss of the original amount invested.
